Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiopulmonary Disease: early-phase trial registry
1 of 5 indexed Cardiopulmonary Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Cardiopulmonary Disease: 5 US clinical trials tracked, 1 recruiting.
Cardiopulmonary Disease is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Analog Device, running 1 of these trials.
Enrollment posture brief
Registry condition cardiopulmonary-disease
OPEN 1 | RECR 20% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Cardiopulmonary Disease lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiopulmonary Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiopulmonary Disease is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cardiopulmonary Disease research.
Analog Device accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiopulmonary Disease enrolment sits around 424 participants.
Median target enrolment is 424 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Cardiopulmonary Disease research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Baystate Medical Center
NCT05733767
World Trade Center (WTC) CHEST
Icahn School of Medicine at Mount Sinai
NCT01466218
Effects of Secondhand Smoke on Flight Attendant Health
University of California, San Francisco
NCT01639235
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
NYU Langone Health
NCT02671669
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
Analog Device
NCT04865640
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiopulmonary Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiopulmonary Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiopulmonary Disease page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cardiopulmonary Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Analog Device sponsors the most Cardiopulmonary Disease trials on record, review their full trial history before evaluating a specific study. See Analog Device's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiopulmonary Disease condition card totals 5 registered trials; most-linked intervention Movn application (MVN); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.